Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Spermicide clinicals in literature lack modern design standards.

This article was originally published in The Tan Sheet

Executive Summary

SPERMICIDE CLINICAL TRIALS SUFFER FROM LACK OF MODERN DESIGN STANDARDS, execution, analysis and reporting, Princeton University Office of Population Research Director James Trussell, PhD, told a joint meeting of four FDA advisory committees. Trussell presented a review and analysis of the existing data supporting the contraceptive efficacy of spermicides to the Reproductive Health Drugs, Nonprescription Drugs, Anti-Infective Drugs and Antiviral Drugs Advisory Committees at a Nov. 20-22 meeting in Gaithersburg, Md.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS086410

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel